国际肿瘤学杂志
國際腫瘤學雜誌
국제종류학잡지
JOURNAL OF INTERNATIONAL ONCOLOGY
2014年
3期
226-228
,共3页
孙姗姗%张月蒙%高英杰%高文仓
孫姍姍%張月矇%高英傑%高文倉
손산산%장월몽%고영걸%고문창
肿瘤转移%二膦酸盐类%地诺单抗
腫瘤轉移%二膦痠鹽類%地諾單抗
종류전이%이련산염류%지낙단항
Neoplasm metastases%Diphosphonates%Denosumab
骨改良药是一类缓解因骨转移引起的疼痛、病理性骨折、脊髓压迫、高钙血症等一系列骨相关事件药物的总称.目前主要有双膦酸盐类药物和地诺单抗.骨改良药应用于证实有骨质破坏的骨转移患者,作为化疗、放疗的辅助用药,可以明显提高疗效,延长患者的生存期.此外,中医中药也可以有效缓解骨转移引起的一系列相关症状,改善预后.临床工作中要选择合理的药物,才能最大限度地降低骨转移患者的痛苦,提高生活质量.
骨改良藥是一類緩解因骨轉移引起的疼痛、病理性骨摺、脊髓壓迫、高鈣血癥等一繫列骨相關事件藥物的總稱.目前主要有雙膦痠鹽類藥物和地諾單抗.骨改良藥應用于證實有骨質破壞的骨轉移患者,作為化療、放療的輔助用藥,可以明顯提高療效,延長患者的生存期.此外,中醫中藥也可以有效緩解骨轉移引起的一繫列相關癥狀,改善預後.臨床工作中要選擇閤理的藥物,纔能最大限度地降低骨轉移患者的痛苦,提高生活質量.
골개량약시일류완해인골전이인기적동통、병이성골절、척수압박、고개혈증등일계렬골상관사건약물적총칭.목전주요유쌍련산염류약물화지낙단항.골개량약응용우증실유골질파배적골전이환자,작위화료、방료적보조용약,가이명현제고료효,연장환자적생존기.차외,중의중약야가이유효완해골전이인기적일계렬상관증상,개선예후.림상공작중요선택합리적약물,재능최대한도지강저골전이환자적통고,제고생활질량.
Bone-modifying agents (BMA) is a series drugs to alleviate the pain,pathological fractures,spinal cord compression,hypercalcemia,bone-related events which induced by bone metastases.Bisphosphonate drugs and denosumab are two dominant kinds of BMA at present.It has been proved that BMA is used in bone metastases patients with bone destruction,as adjuvant therapy for chemotherapy and radiotherapy,which can significantly improve the efficacy and prolong the survival of patients.In addition,some traditional Chinese medcine can effectively relieve a series of related symptoms caused by bone metastases and improve prognosis.Choosing right medication in clinical work can maximize the reduction of pain caused by bonerelated events and improve the quality of life of patients.